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Following publication of the original article \[[@CR1]\], the authors identified errors in Fig. 8d and f. The corrected Fig. [8](#Fig8){ref-type="fig"} and the corrected figure caption are given below.Fig. 8ATX-LPN partially rescue CDDP-induced hearing loss. **a** In vitro culture of Organ of Corti. CDDP induced a significant loss of hair cells (Myosin VII, red), especially in the high-frequency areas. **b** Survival outer hair cell numbers in 1 mm length at different locations from apical end of each group. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 as compared with CDDP, ^\#^p \< 0.05 as compared with ATX + CDDP. **c**--**e** Mean ABR threshold of mice treated with cisplatin, ATX 1 mg/ml, 5 μl. ATX-LPN + CDDP. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 as compared with CDDP, ^\#^p \< 0.05 as compared with ATX + CDDP. **f** Immunohistochemistry of cochlea in apex/middle/basal area of BM. The pretreatment of protective drugs (ATX/ATX-LPN) effectively reduced the expression of caspase-3 (red fluorescence) and rescued more OHCs (green fluorescence)
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